The management team of Cognos Therapeutics Inc. (Cognos) is committed to excellence in leadership and strategic innovation in its pursuit of the vision and goals established by the Cognos Board of Directors. The executive team is comprised of seasoned and forward thinking individuals who have each achieved success in their areas of expertise with previous companies. Not only is their leadership well recognized, but more importantly is their ability to inspire and direct the teams and individuals who are working to bring Cognos’ unique product technology to commercial viability.
Chief Executive Officer
Frank Adell is a successful entrepreneur and business leader with over 30-years of experience in strategic planning. In addition to being the Chief Executive Officer, Mr. Adell also serves as a key member on the Cognos Board of Directors.
Chief Innovation Officer
Josh Shachar has been involved in the innovation and development of advanced technologies for private and government agencies for over 20 years. Mr. Shachar’s vision is foundational to the development of Cognos’ product technology.
Thomas Chen, MD, PhD
Chief Neuro-Surgeon and Oncology Officer
Dr. Thomas Chen is a physician, a board certified neurosurgeon, and the Director of Surgical Neuro-oncology at USC. His ability to bridge innovative vision and real-world application is critical to the Cognos mission.
Winston Wu, PhD
Senior Vice President of Product Development and Chief Technology Officer
Dr. Winston Wu is the Senior Vice President for Product Development as well as the Chief Technology Officer for Cognos. He is recognized for his experience in building highly skilled teams for taking complex medical technologies from concept to commercialization.
Thomas Lobl, PhD
Chief Operating Officer
As Chief Operating Officer for Cognos, Dr. Lobl brings over four decades of experience in the successful development and growth of medical technology companies. He is responsible for the strategic management of Cognos’ resources as well as the implementation of effective processes and team alignment in the operation of the company.
Dr. Ian Welsford, PhD
Chief Regulatory and Compliance Office
Dr. Welsford has over 25 years of experience in quality assurance, regulatory affairs, and clinical affairs dealing with regulatory issues associated with medical devices, drugs, and combination products.
Manager, Special Medical Device Regulatory and Compliance
Darci Diage has over 18 years of experience in the medical device industry focusing on manufacturing, design control, risk management and concept to commercial product development activities including preclinical and clinical submissions.